The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Better information on medicine labels - have your say
Australia's medicine's regulator, the Therapeutic Goods Administration, has today released a consultation paper that explores new ways of helping consumers better understand information on medicine labels and packaging.
The discussion paper follows a major review of packaging and labelling by the TGA designed to improve information that is presented to patients and consumers on how to take their medicines safely and effectively.
In addition to better information for consumers, prescribing doctors and pharmacists will be assisted by clearer and more uniform labelling to avoid confusion when they dispense medicines with similar packaging.
This discussion paper looks at very basic issues like active ingredient prominence, space for dispensing stickers, small container label requirements, umbrella branding, pack inserts, blister pack labelling and standardisation of label information.
The consultation paper applies to all medicines whether they are purchased from a supermarket or a pharmacy without a prescription, or following a consultation with a doctor and the pharmacist at the point of dispensing. The consultation paper can be found at: TGA medicine labelling and packaging review.
The consultation opened on 24 May 2012 and closes on 24 August 2012.
The TGA will also have copies of the discussion paper at the National Medicines Symposium on 24 & 25 May 2012.